| 영문 | Dilatation and Curettage(D & C) | 한글 | 자궁긁어냄술, 자궁목확장 |
|---|---|---|---|
| 설명 | 자궁이란 태아가 수태되어서 분만전까지 발육하고 성장하는 공간이다. 자궁속에 병변이 있어 임신이 계속될 수 없거나 아니면 다른 이유로 임신되어 있는 태아를 제거하고자 할 경우에 사용되는 방법이다. 여기서 긁어내기 위하여는 우선 자궁의 입구에 해당하는 자궁목을 확장시켜야 한다. 여기에는 급속히 확장을 시도하는 법과 서서히 확장을 시도하는 2가지 방법이 있다. 자궁목을 급속히 확장할 때는 헤가르 목관확장기(Hegar's dilatator)를 사용한다. 이것은 작은 금속막대로 작은 크기부터 큰 크기까지 다양한 크기가 있어서 우선 작은 막대로 시작하여 점점 큰 크기의 막대를 자궁목에 넣어서 자궁목을 확장시킨다. 서서히 확장시킬 때는 Laminaria tent를 목관에 삽입하는 방법을 사용한다. Laminaria tent란 해초로 만든 작은 막대로 수분을 흡수하면 점점 늘어나는 성질이 있다. 이것을 자궁의 목에 넣으면 이것이 수분을 흡수하여 늘어나므로 천천히 자궁의 목이 늘어난다. 자궁목이 충분히 늘어나면 그 속으로 끝이 숟가락처럼 생긴 기구를 넣어서 자궁속의 병변이나 임신된 태아를 긁어내는데 여기에 사용되는 숟가락처럼 생긴 기구를 큐렛이라고 한다. 초기 임신중절 즉 유산과 같은 임신과 관련된 경우뿐만 아니라, 비임신 자궁의 자궁내막조직의 채취 및 제거를 위해서도 행해지는 수기이다. 이는 원칙적으로 마취하에 실시되는 것으로 자궁목관을 확장하고 기구로 자궁 내용물을 제거하고 큐렛으로 자궁내벽을 깨끗이 한다. 자궁천공이나 자궁목의 파열 등의 위험이 따르며, 수술후 감염 또는 출혈 등에 대한 주의가 필요하다. |
||
| NIH | National Institutes of Health |
|---|---|
| HHMI | Howard Hughes Medical Institutes |
| NIEHS | National Institutes of Environmental Health Sciences |
| NIH | National Institutes of Health |
| NPA-NIHHDP | National Pituitary Agency-National Institutes of Health Hormone Distribution Program |
| ( NIH | National Institutes of Health |
|---|---|
| JAMA | Journal of the American Medical Association |
| NEJM | New England Journal of Medicine |
| ACCESS | Access to Community Care and Effective Services and Support |
acute angle
| academies and institutes | Organizations representing specialised fields which are accepted as authoritative; may be non-governmental, university or an independent research organization, e.g., national academy of sciences, brookings institution, etc. (12 Dec 1998) |
|---|---|
| journal article | The predominant publication type for articles and other items indexed for nlm databases. (12 Dec 1998) |
| National Institutes of Health | <organisation> A nonregulatory U.S. Federal agency which has oversight of research activities that the agency funds. (09 Oct 1997) |
| Barcroft-Warburg apparatus | An apparatus for measuring the oxygen consumption of incubated tissue slices by manometric measurement of changes in gas pressure produced by oxygen absorption in an enclosed flask. Synonym: Barcroft-Warburg apparatus. (05 Mar 2000) |
| Barcroft-Warburg technique | An apparatus for measuring the oxygen consumption of incubated tissue slices by manometric measurement of changes in gas pressure produced by oxygen absorption in an enclosed flask. Synonym: Barcroft-Warburg apparatus. (05 Mar 2000) |
| Warburg-Dickens-Horecker shunt | <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate. Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses. In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection. Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose. (18 Nov 1997) |
| Warburg-Lipmann-Dickens-Horecker shunt | <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate. Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses. In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection. Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose. (18 Nov 1997) |
| Warburg, Otto | <person> German biochemist and Nobel laureate, 1883-1970. See: Warburg's apparatus, Warburg's respiratory enzyme, Warburg's old yellow enzyme, Warburg's theory, Warburg-Lipmann-Dickens-Horecker shunt, Barcroft-Warburg apparatus, Barcroft-Warburg technique. (05 Mar 2000) |
| Warburg's apparatus | An apparatus for measuring the oxygen consumption of incubated tissue slices by manometric measurement of changes in gas pressure produced by oxygen absorption in an enclosed flask. Synonym: Barcroft-Warburg apparatus. (05 Mar 2000) |
| Warburg's old yellow enzyme | <enzyme> A flavoprotein that reversibly oxidises NADPH to NADP and a reduced acceptor. Chemical name: NADPH:(acceptor) oxidoreductase Registry number: EC 1.6.99.1 (12 Dec 1998) |
| Warburg's respiratory enzyme | 1. A system of cytochromes and their oxidases that participate in respiratory processes. 2. Often, specifically, cytochrome oxidase. Synonym: Warburg's respiratory enzyme. Origin: Ger. (05 Mar 2000) |
| Warburg's theory | That the development of cancer is due to irreversible damage to the respiratory mechanism of cells, leading to the selective multiplication of cells with increased glycolytic metabolism, both aerobic and anaerobic. (05 Mar 2000) |
| warburg's tincture | <pharmacology> A preparation containing quinine and many other ingredients, often used in the treatment of malarial affections. It was invented by Dr. Warburg of London. Source: Websters Dictionary (01 Mar 1998) |
| abstracting and indexing | Shortening or summarizing of documents; assigning of descriptors for referencing documents. (12 Dec 1998) |
| accounts payable and receivable | Short-term debt obligations and assets occurring in the regular course of operational transactions. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|